Olanow, C Warren

Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins. [electronic resource] - Movement disorders : official journal of the Movement Disorder Society 02 2017 - 203-207 p. digital

Publication Type: Journal Article; Comment

1531-8257

10.1002/mds.26935 doi


Humans
Neurons
Parkinson Disease
Substantia Nigra
alpha-Synuclein